Advances in Kidney Transplantation
Uitgelicht
|
62,49 |
Naar shop
|
|
71,00 |
Naar shop
|
|
71,00 |
Naar shop
|
Beschrijving
Bol
Medical practice in kidney transplantation is advancing toward innovative approaches that optimize pharmacological safety, immunosuppressive management, and the prevention of post-transplant complications. This Special Issue compiles studies on the efficacy of finerenone in kidney transplant recipients, selection patterns for kidney transplantation versus dialysis in lung recipients with end-stage renal disease, post-transplant glomerulonephritis recurrence, long-term outcomes in living donors with multiple renal arteries, clinical factors influencing tacrolimus metabolism and formulation comparisons, the use of Torque Teno virus as a marker of net immunosuppression, compatibility of immunosuppressive therapies with lactation, and the superiority of LCPT tacrolimus in preventing post-transplant diabetes in high-risk patients.These works highlight advances in non-invasive biomarkers, optimization of immunosuppressants such as extended-release tacrolimus, and strategies to mitigate risks like glomerular recurrence, post-transplant diabetes, and over-immunosuppression. The focus on prospective cohorts and narrative reviews underscores the importance of personalizing treatment to improve graft survival and long-term clinical outcomes in complex populations, including living donors and patients with comorbidities. This Reprint collects key evidence to guide clinical decisions in transplant nephrology.
Medical practice in kidney transplantation is advancing toward innovative approaches that optimize pharmacological safety, immunosuppressive management, and the prevention of post-transplant complications. This Special Issue compiles studies on the efficacy of finerenone in kidney transplant recipients, selection patterns for kidney transplantation versus dialysis in lung recipients with end-stage renal disease, post-transplant glomerulonephritis recurrence, long-term outcomes in living donors with multiple renal arteries, clinical factors influencing tacrolimus metabolism and formulation comparisons, the use of Torque Teno virus as a marker of net immunosuppression, compatibility of immunosuppressive therapies with lactation, and the superiority of LCPT tacrolimus in preventing post-transplant diabetes in high-risk patients.These works highlight advances in non-invasive biomarkers, optimization of immunosuppressants such as extended-release tacrolimus, and strategies to mitigate risks like glomerular recurrence, post-transplant diabetes, and over-immunosuppression. The focus on prospective cohorts and narrative reviews underscores the importance of personalizing treatment to improve graft survival and long-term clinical outcomes in complex populations, including living donors and patients with comorbidities. This Reprint collects key evidence to guide clinical decisions in transplant nephrology.
AmazonPagina's: 134, Hardcover, MDPI AG